02628 PE Ratio & Valuation,Is 02628 Overvalued

02628 Relative Valuation

02628's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 02628 is overvalued; if below, it's undervalued.

Historical Valuation

CHINA LIFE (02628) is now in the Fair zone, suggesting that its current forward PE ratio of 7.49 is considered Fairly compared with the five-year average of 6.06. The fair price of CHINA LIFE (02628) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：31.14

Fair

7.49

0.00

EV/EBITDA

CHINA LIFE. (02628) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

11.84

EV/EBIT

CHINA LIFE. (02628) has a current EV/EBIT of 11.84. The 5-year average EV/EBIT is 17.91. The thresholds are as follows: Strongly Undervalued below 1.56, Undervalued between 1.56 and 9.73, Fairly Valued between 26.08 and 9.73, Overvalued between 26.08 and 34.25, and Strongly Overvalued above 34.25. The current Forward EV/EBIT of 11.84 falls within the Historic Trend Line -Fairly Valued range.

1.69

CHINA LIFE. (02628) has a current PS of 1.69. The 5-year average PS is 1.20. The thresholds are as follows: Strongly Undervalued below 0.80, Undervalued between 0.80 and 1.00, Fairly Valued between 1.40 and 1.00, Overvalued between 1.40 and 1.59, and Strongly Overvalued above 1.59. The current Forward PS of 1.69 falls within the Strongly Overvalued range.

3.55

P/OCF

CHINA LIFE. (02628) has a current P/OCF of 3.55. The 5-year average P/OCF is 3.06. The thresholds are as follows: Strongly Undervalued below 0.30, Undervalued between 0.30 and 1.68, Fairly Valued between 4.44 and 1.68, Overvalued between 4.44 and 5.82, and Strongly Overvalued above 5.82. The current Forward P/OCF of 3.55 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

CHINA LIFE. (02628) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

CHINA LIFE (02628) has a current Price-to-Book (P/B) ratio of 1.21. Compared to its 3-year average P/B ratio of 0.79 , the current P/B ratio is approximately 53.32% higher. Relative to its 5-year average P/B ratio of 0.74, the current P/B ratio is about 62.37% higher. CHINA LIFE (02628) has a Forward Free Cash Flow (FCF) yield of approximately 37.53%. Compared to its 3-year average FCF yield of 45.47%, the current FCF yield is approximately -17.45% lower. Relative to its 5-year average FCF yield of 44.63% , the current FCF yield is about -15.91% lower.

1.21

P/B

Median3y

0.79

Median5y

0.74

37.53

FCF Yield

Median3y

45.47

Median5y

44.63

Performance Decomposition

Market capitalization of 02628 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of 02628 in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CHINA LIFE (02628) currently overvalued or undervalued?

What is CHINA LIFE (02628) fair value?

02628's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of CHINA LIFE (02628) is between to according to relative valuation methord.

How does 02628's valuation metrics compare to the industry average?

The average P/S ratio for 02628's competitors is , providing a benchmark for relative valuation. CHINA LIFE Corp (02628) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for CHINA LIFE (02628) as of Jan 08 2026?

As of Jan 08 2026, CHINA LIFE (02628) has a P/B ratio of 1.21. This indicates that the market values 02628 at 1.21 times its book value.

What is the current FCF Yield for CHINA LIFE (02628) as of Jan 08 2026?

As of Jan 08 2026, CHINA LIFE (02628) has a FCF Yield of 37.53%. This means that for every dollar of CHINA LIFE’s market capitalization, the company generates 37.53 cents in free cash flow.

What is the current Forward P/E ratio for CHINA LIFE (02628) as of Jan 08 2026?

As of Jan 08 2026, CHINA LIFE (02628) has a Forward P/E ratio of 7.49. This means the market is willing to pay $7.49 for every dollar of CHINA LIFE’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for CHINA LIFE (02628) as of Jan 08 2026?

As of Jan 08 2026, CHINA LIFE (02628) has a Forward P/S ratio of 1.69. This means the market is valuing 02628 at $1.69 for every dollar of expected revenue over the next 12 months.

02628 Valuation